Abstract
Amoxicillin is commonly used for the treatment of neonatal bacterial infection with intermittent dosing (ID) regimens. However, increasing bacterial resistance, in addition to a lack of new antimicrobial agents, urges the optimization of current therapeutic options. Clinical studies in adults suggest continuous infusion (CI) regimens of beta-lactam antibiotics to be superior to ID. There are as yet no guidelines concerning the CI dosing of amoxicillin. The present study was developed to describe the CI pharmacokinetics and -dynamics of amoxicillin during the first 3 days of life in search of the optimal dosing regimen. Neonates with a gestational age above 34 weeks, at risk of neonatal infection and requiring amoxicillin therapy, were included. Serum concentrations of amoxicillin were measured during CI on days 1 and 3 in the steady state. Twenty-two serum samples of 11 patients were collected. All patients reached and retained serum concentrations of amoxicillin within the therapeutic range without exceeding the toxic concentration (serum concentrations on day 1 mean 55.4 mg/l, range 30.9–69.5, SD 10.5, and on day 3 48.8 mg/l, range 25.5–92.4, SD 18.4). There was no significant decrease in concentration from day 1 to day 3 (p = 0.38). This study showed therapeutic, nontoxic concentrations of amoxicillin in neonates on CI of amoxicillin in the first 3 days of life. Randomized controlled trials should reveal whether the clinical benefits of the CI of amoxicillin exceed those of ID regimens.
Similar content being viewed by others
References
Mouton JW, Vinks AA (2009) Continuous infusion of beta-lactams. Curr Opin Crit Care 13:598–606
Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing in mice and men. Clin Infect Dis 26:1–10
Muller AE, Punt N, Mouton JW (2013) Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia. J Antimicrob Chemother 68:900–906
Craig WA, Ebers SC (1992) Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 36:2577–2583
Kasiakou SK, Sermaides GJ, Michalapoulos A, Soteriades ES, Falagas ME (2005) Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis 5:581–589
Roberts JA, Lipman J, Blot S, Rello J (2008) Better outcomes through continuous infusion in time-dependent antibiotics to critically ill patients? Curr Opin Crit Care 14:390–396
Roberts JA, Webb S, Paterson D, Ho KM, Lipman J (2009) A systematic review on clinical benefits of continuous administration of β-lactam antibiotics. Crit Care Med 37:2071–2078
MacGowan A (2011) Revisiting beta-lactam- PK/PD improves dosing of old antibiotics. Curr Opin Pharmacol 11:470–476
Abdul-Aziz MH, Staatz CE, Kirkpatrick CMJ, Lipman J, Roberts JA (2011) Continuous infusion vs. Bolus dosing: implications for beta-lactam antibiotics. Minerva Anesthesiol 77:1–2
Tamma PD, Pucha N, Suh YD, van Arendonk KJ, Rinke ML (2001) Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomize, controlled trials. BMC Infect Dis 11:181–192
Dulhunty JM, Roberts JA, Davis JS et al (2013) Continuous infusion of beta lactam antibiotics in severe sepsis: a multicenter double-blind, randomised controlled trial. Clin Infect Dis 56:236–244
Falagas EM, Tansarli GS, Ikawa K, Vardakas KZ (2013) Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam a systematic review and meta-analysis. Clin Infect Dis 56:272–282
Brody TM, Larner J, Minneman KP (1998) Human pharmacology—molecular to clinical. Mosby, St Louis
Shaffer CL, Davey AM, Ransom JL, Brown YL, Gal P (1998) Ampicillin-induced neurotoxicity in very-low-birth-weight neonates. Ann Pharmacother 32:482–484
Jones DP, Gaber L, Nilsson GR (1993) Acute renal failure following amoxicillin overdose. Clin Pediatr (Phila) 32:735–739
Huisman-de Boer JJ, van den Anker JN, Voel M, Goessens WHF, Schoemaker RC, de Groot R (1995) Amoxicillin pharmacokinetics in preterm infants with gestational ages less than 32 weeks. Antimicrob Agents Chemother 39:431–434
Charles BG, Preechagoon Y, Lee TC, Steer PA, Flenady VJ, Debuse N (1997) Population pharmacokinetics of intravenous amoxicillin in very low birth weight infants. J Pharm Sci 86:1288–1292
Pullen J, Stolk LM, Nieman FH, Degraeuwe PL, van Tiel FH, Zimmermann LJ (2006) Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. Ther Drug Monit 28:226–231
Pullen J, Driessen M, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ (2007) Amoxicillin pharmacokinetics in (preterm) infants aged 10 to 52 days: effect of postnatal age. Ther Drug Monit 29:376–380
Bertels RA, Semmekrot BA, Gerrits GP, Mouton JW (2008) Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion. Infection 36:415–420
Muller AE, Dörr PJ, Mouton JW, De Jongh J, Oostvogel PM, Steegers EAP et al (2008) The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women. Br J Clin Pharmacol 66:866–874
Blake MJ, Castro L, Leeder JS, Kearns GL (2005) Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123–138
Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology—drug disposition, action and therapy in infants and children. N Engl J Med 349:1157–1167
Coulthard MG (1985) Maturation of glomerular filtration in preterm and mature babies. Early Hum Dev 11:281–292
Arant BS (1975) Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 92:705–712
Cook B, Hill SA, Lynn B (1982) The stability of amoxycillin sodium in intravenous infusion fluids. J Clin Hosp Pharm 7:245–250
Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB (1986) Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states. Am J Hosp Pharm 43:3027–3030
McDonald C, Sunderland VB, Lau H, Shija R (1989) The stability of amoxicillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states. J Clin Pharm Ther 14:45–52
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was obtained for this research.
Conflicts of interest
The authors have no conflicts of interest to declare.
Ethical approval
The Central Committee of Ethics (CCMO) approved the study. The study was performed following Good Clinical Practice Guidelines.
Informed consent
Written informed consent was obtained from both parents.
Rights and permissions
About this article
Cite this article
van Boekholt, A., Fleuren, H., Mouton, J. et al. Serum concentrations of amoxicillin in neonates during continuous intravenous infusion. Eur J Clin Microbiol Infect Dis 35, 1007–1012 (2016). https://doi.org/10.1007/s10096-016-2630-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2630-z